Every Oncologist Said the Same Thing. One Surgeon in Shanghai Disagreed.
A woman in her late 40s presented with hepatocellular carcinoma complicated by portal vein tumor thrombus (PVTT) — a condition widely considered a contraindication for surgical intervention. She had been refused treatment at two major regional hospitals and referred abroad, only to receive the same verdict. She was offered palliative chemotherapy and told to manage her expectations.
Her family refused to accept it. They brought her scans to Dr. Zhou Jian at Zhongshan Hospital, Fudan University. He proposed a staged approach: preoperative TACE to shrink the thrombus and reduce tumor burden, followed by radical hepatic resection with portal vein reconstruction. The surgery was technically demanding and took over eight hours. The result was complete tumor clearance with clear margins. Two years post-surgery, she remains disease-free and has returned to full-time work.
Cases that are refused elsewhere are being solved in Shanghai. The expertise exists. The access is possible.
Understanding Portal Vein Tumor Thrombus: Why Most Surgeons Won’t Operate
Portal vein tumor thrombus is one of the most feared complications of hepatocellular carcinoma — and one of the most misunderstood in terms of surgical potential:
- PVTT defined — tumor cells invade the portal vein, forming a thrombus that obstructs blood flow to the liver and dramatically increases the risk of metastatic spread
- Standard-of-care refusal — most international guidelines classify PVTT as a contraindication for surgery, defaulting to systemic therapy or sorafenib
- The staging advantage — preoperative TACE (transarterial chemoembolization) can shrink the thrombus and reduce tumor burden, converting some patients from inoperable to operable
- Portal vein reconstruction — in expert hands, the involved segment of portal vein can be resected and reconstructed, achieving clear vascular margins
- Volume and experience — PVTT surgery is only performed routinely at a handful of centers globally; outcomes are directly tied to institutional experience and surgeon volume
About Dr. Zhou Jian 周信
Dr. Zhou Jian is Chief Physician and Professor of Liver Tumor Surgery at Zhongshan Hospital, Fudan University — a nationally recognized authority in complex hepatic resection and one of very few surgeons in China who routinely operates on portal vein tumor thrombus cases. His outcomes in this category are among the best documented in the country.
His clinical expertise spans:
- Hepatic resection with PVTT — radical surgery for HCC complicated by portal vein invasion, including vascular reconstruction
- Staged TACE-to-surgery protocols — converting inoperable patients through preoperative tumor burden reduction
- Portal vein reconstruction — resection and repair of involved vascular segments to achieve clear oncological margins
- Complex hepatocellular carcinoma — high-volume experience with advanced-stage HCC cases refused at other institutions
- Multidisciplinary liver oncology — integrating interventional radiology, oncology, and hepatic surgery for individualized treatment planning
The Case That Defied the Consensus
The Diagnosis
Hepatocellular carcinoma with portal vein tumor thrombus. Two major hospitals refused surgery. A referral abroad produced the same answer: palliative chemotherapy only. Her family was told to manage expectations.
The Plan
Dr. Zhou Jian reviewed the imaging and saw a different path. The staged approach: preoperative TACE to shrink the thrombus and reduce tumor burden, followed by radical hepatic resection with portal vein reconstruction once the tumor had responded sufficiently.
The Surgery
The operation was technically demanding and took over eight hours. Dr. Zhou’s team resected the tumor and reconstructed the involved portal vein segment. The pathology confirmed what the surgical team had achieved: complete tumor clearance with clear margins.
The Recovery
She recovered steadily. At the two-year follow-up, she remains disease-free — and has returned to full-time work.
Outcome Summary
- ✅ Complete tumor clearance — radical resection with clear oncological margins confirmed on pathology
- ✅ Portal vein reconstruction successful — vascular integrity restored following resection of involved segment
- ✅ TACE-to-surgery conversion — staged preoperative treatment enabled surgery in a case classified as inoperable elsewhere
- ✅ Disease-free at two years — no recurrence on follow-up imaging
- ✅ Returned to full-time work — complete functional recovery
“The cancer had invaded the portal vein. Every oncologist she saw said the same thing: surgery is not an option. Palliative care only.” Her family refused to accept it — and they were right not to.”
Why Shanghai for Advanced Liver Cancer Surgery?
- PVTT surgical expertise — Zhongshan Hospital is one of a small number of centers globally that performs portal vein tumor thrombus resection routinely, with documented outcomes
- Staged treatment protocols — TACE-to-surgery conversion pathways are embedded in standard clinical practice, not experimental
- Vascular reconstruction capability — portal vein resection and reconstruction requires specialized surgical and anesthesia teams; Shanghai’s top centers have them
- Multidisciplinary oncology integration — interventional radiology, hepatic surgery, and oncology collaborate on every complex case from day one
- Significant cost advantage — advanced liver cancer surgery in Shanghai costs a fraction of equivalent care in the US, UK, or Australia, with no compromise on outcome
How CMCS Supports International Patients Seeking Liver Cancer Surgery
- 🏥 Specialist matching — identifying the right hepatic surgeon for your specific tumor profile, vascular involvement, and prior treatment history
- 📋 Medical record and imaging translation & second opinion coordination
- 🗣️ On-site medical interpretation at every consultation, procedure, and follow-up
- ✈️ Travel & logistics coordination — visa, accommodation, airport transfers
- 📞 24/7 concierge support from first inquiry through every stage of treatment
- 🔄 Post-treatment follow-up — ongoing oncology monitoring and recovery support
📢 Subscribe to China Medical Concierge – Shanghai (CMCS)
We offer trusted medical tourism and personalized medical concierge services, giving you and your loved ones a reliable pathway to premium healthcare in China.
💬 Got questions? Drop a comment or send a DM – we’re always here to help!
📢 Have your own incredible medical story in China? Share it with us in the comments below!
#ChinaMedicalTour #AffordableHealthcare #MedicalTourismChina #BritishInChina #ChinaHealthcare #MedicalConcierge #medicaltourismchina
🤝 Connect With CMCS
Struggling with long medical waitlists? Facing barriers to overseas treatment? China Medical Concierge - Shanghai (CMCS) helps international patients access premium medical care in Shanghai’s top public & private hospitals, with end-to-end personalized support.
Contact us for international patient support:
📧 contract@medicalsh.com | 🌐 medicalsh.com
댓글 0개